Pfizer plans layered pricing in India, free shots in Africa Kumar Jeetendra | December 9, 2020 Pfizer Inc has decided to price its COVID-19 vaccine candidate, BNT162b2 COVID-19, on the basis of the GDP of the country. The Chief Executive Officer of the American pharmaceutical company, Albert Bourla, has said the company will have tiered pricing to its middle-income nations, including India. The COVID-19 vaccine developed by Pfizer and BioNTech was …
Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its corona vaccine Kumar Jeetendra | December 7, 2020 China’s Sinovac Biotech has secured $515 million in financing from a local company to double manufacturing capacity of its coronavirus vaccine, the companies said on Monday, as it anticipates efficacy data of its experimental shot this month. The investment deal also comes as Sinovac expands provide deals and trials of its experimental COVID-19 vaccine CoronaVac …
Pfizer Seeks Emergency Use approvals For Its COVID-19 Vaccine In India Kumar Jeetendra | December 6, 2020 Pfizer India has submitted an application on December 4 to the DCGI hunting emergency use authorization (EUA) for its COVID-19 vaccine in India. The firm has filed the EUA program in Form CT-18 for grant of permission to import and market Pfizer-BioNTech’s COVID-19 mRNA vaccine BNT162b2 in the nation,” the source said, citing the program. …
Artificial Intelligence, Machine Learning To Play an important Role In Fight Against COVID, Say Experts Kumar Jeetendra | December 5, 2020 Artificial intelligence (AI) and machine learning are helping analyse enormous amounts of data around the human genome and drug molecules, and these new-age technologies can play an important role in the battle against COVID-19, industry experts said on Saturday. Speaking at KnowDis Machine Learning Day, Avantika Lal – Senior Scientist (Deep Learning and Genomics) at …
Fermenta Biotech USA, LLC acquires 52% interest in AGD Nutrition LLC Kumar Jeetendra | December 5, 2020 Fermenta Biotech Limited (FBL), India has announced that its wholly owned subsidiary Fermenta Biotech USA LLC (FBU), Wilmington, DE, has acquired a 52% stake in a US-based vitamin company, AGD Nutrition LLC (AGD), headquartered in Nacogdoches, Texas. The deal would combine the expertise of both companies and result in synergies that will bring in greater …
DT-109 Significantly Prevents Progression of Diet-Induced Non-Alcoholic Fatty Liver Disease Kumar Jeetendra | December 4, 2020 Ann Arbor, MI – December 4, 2020 – Life Science Newswire – Rom et al report today that the oral administration of the simple tri-peptide, DT-109 (Patent US8664177B2), prevents both development of non-alcoholic fatty liver disease (NAFLD) and late stage fibrosis in a murine model of diet-induced non-alcoholic steatohepatitis (NASH). The study titled, “Glycine-based treatment …
Rhizen Pharma gets USFDA endorsement for stage one clinical preliminaries for Covid-19 drug Kumar Jeetendra | December 3, 2020 New Delhi, Dec 2 (PTI) Rhizen Pharmaceuticals, a member firm of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral oral drug for the treatment of COVID-19. The Switzerland-based firm, which will be a clinical-stage oncology-focussed biopharmaceutical company, has obtained approval for …
Alembic Pharma gets USFDA endorsement for Metolazone tablets Kumar Jeetendra | December 3, 2020 New Delhi, Dec 3 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for Metolazone tablets, indicated for the treatment of salt and water retention caused by heart failure or kidney disease. The approved product is therapeutically equivalent to the reference listed drug product Zaroxolyn Tablets 2.5 …
Dr Reddy’s, RDIF start clinical preliminaries for Russia’s Sputnik V COVID-19 vaccine in India Kumar Jeetendra | December 2, 2020 Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) announced on December 1 the commencement of elastic phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving mandatory clearance from the Central Drugs Laboratory, Kasauli in Himachal Pradesh. The Indian drug maker said this will be a multi-centre and randomised …
Keeping Your Chemical Facility Updated: Ways To Improve Maintenance Kumar Jeetendra | December 2, 2020 The chemical industry has been one of the leading sectors in industrial automation for years, where more and more complex systems are being brought together that are allowing to highly improve competitiveness. All this in an environment where safety and environmental regulations are among the most demanding. Therein lies the value of turning maintenance into …
A new nanoemulsion eye drop formulation of a small molecule RUNX1 inhibitor Kumar Jeetendra | November 30, 2020 Boston, MA – 30 November 2020 – Life Science Newswire – A team led by Mass Eye and Ear researchers has developed an eye drop to effectively deliver drugs to the retina and other tissues located in the back of the eye, a new technology with potential application for the treatment of multiple blinding diseases. …
Generis Partner with Cognizant to Deliver Innovative Information Management and Structured Content Authoring Solutions to the Life Sciences Kumar Jeetendra | November 30, 2020 London, UK – 30 November 2020 – Life Science Newswire – Generis, a leader in content and information management systems for regulated industries, announces its strategic partnership with Cognizant, a global provider of information technology, consulting, and business process services, to deliver innovative information management solutions for Life Sciences. This partnership will see Cognizant leverage Generis’ …
